Clinical Trial Update: Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity [Phase 2]

View source ↗

Summary

Phase 2 safety study of botulinum toxin type A for focal upper limb post-stroke spasticity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Spasticity
• Stroke

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Stroke, Muscle Spasticity | Phase 2 | Status: COMPLETED